NASDAQ$PLXS
Plexus Corp · Q4 2020 earnings
Q4 2020 earnings · · Investor relations
Briefing
Achieved record revenue and GAAP diluted earnings per share, both exceeding the top end of guidance ranges.
Plexus announced record fiscal fourth quarter revenue of $913 million and GAAP diluted EPS of $1.26, exceeding guidance. Strong demand in the Healthcare/Life Sciences and Industrial/Commercial sectors fueled growth. Free cash flow for the quarter was $109 million, and the company exited the year with record free cash flow of $160 million.
- Record fiscal fourth quarter revenue of $913 million.
- GAAP diluted EPS of $1.26, including $0.23 of stock based compensation expense.
- Won 44 manufacturing programs during the quarter representing $286 million in annualized revenue when fully ramped into production.
- Generated $109 million in free cash flow during the fiscal fourth quarter.
Headline financials
Revenue & EPS history
Plexus · Revenue · Quarterly
$913M
Revenue by segment
Plexus · $837M total across 2 segments · Q4 2020
- Asia-Pacific$503M—60.1%
- Americas$334M—39.9%
Forward guidance
Plexus expects demand to moderate in the fiscal first quarter of 2021 and is guiding revenue in the range of $810 to $850 million. The company projects continued operating strength and is guiding GAAP operating margin for the quarter in the range of 4.9% to 5.3%. With this strong operating performance, Plexus anticipates delivering GAAP diluted earnings per share of $1.02 to $1.17 for the fiscal first quarter.
Tailwinds
- Revenue guidance of $810 to $850 million for fiscal first quarter 2021.
- GAAP operating margin guidance of 4.9% to 5.3% for fiscal first quarter 2021.
- GAAP diluted earnings per share guidance of $1.02 to $1.17 for fiscal first quarter 2021.
- Expect a return to quarterly sequential revenue growth by the second half of fiscal 2021.
- Anticipate robust operating performance for the fiscal year.
Headwinds
- Demand is expected to moderate in the fiscal first quarter of 2021.
- Guidance assumes that COVID-19 will not materially impact end markets or operations beyond what has already occurred.
- Includes stock-based compensation expense of $0.19 for Q1F21 guidance.
- Unspecified risks related to evolving effect of COVID-19 on employees, customers, suppliers and logistics providers.
- Unspecified risks related to governmental actions being taken to curtail the spread of the virus.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2020
-0.1%
Avg return
Earnings day
-0.1%
Avg return
5 days after
+2.5%
Avg return
30 days after
51%
35 / 68 earnings
Positive
+13.2%
Q1 2016
Best reaction
-18.1%
Q1 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q2 2026 | +2.7% | +5.8% | +7.1% | |
| Q1 2026 | +9.3% | +12.7% | +7.3% | |
| Q4 2025 | +2.8% | -1.7% | -5.2% | |
| Q2 2025 | -1.4% | -1.1% | +1.9% | |
| Q1 2025 | -10.1% | -15.2% | -19.4% | |
| Q4 2024 | +7.5% | +6.3% | +20.2% | |
| Q3 2024 | +9.0% | +6.3% | +7.7% | |
| Q2 2024 | +2.6% | +5.9% | +17.3% | |
| Q1 2024 | -5.1% | -6.7% | -4.2% | |
| Q4 2023 | +5.9% | +9.4% | +17.8% | |
| Q3 2023 | -3.9% | -3.9% | -2.9% | |
| Q2 2023 | -0.5% | +0.0% | +5.4% | |
| Q1 2023 | -18.1% | -19.6% | -16.1% | |
| Q4 2022 | -1.2% | +1.4% | +11.7% | |
| Q3 2022 | +6.5% | +9.6% | +9.9% | |
| Q2 2022 | +6.2% | +6.5% | +9.2% | |
| Q1 2022 | -6.0% | -2.3% | +2.8% | |
| Q4 2021 | -8.0% | -5.8% | -9.8% | |
| Q3 2021 | -0.3% | +1.4% | +2.8% | |
| Q2 2021 | -1.0% | +4.0% | +8.9% | |
| Q1 2021 | -3.7% | -3.2% | +0.6% | |
| Q4 2020 | -3.3% | -1.2% | +8.7% | |
| Q3 2020 | +2.8% | -1.6% | +3.4% | |
| Q2 2020 | +7.0% | +9.9% | +14.7% | |
| Q1 2020 | +2.6% | -3.2% | -7.6% | |
| Q4 2019 | +9.1% | +13.0% | +15.4% | |
| Q3 2019 | -9.1% | -8.4% | -7.1% | |
| Q2 2019 | -7.8% | -8.8% | -17.5% | |
| Q1 2019 | -2.1% | +1.6% | +9.3% | |
| Q4 2018 | +4.1% | +3.1% | +4.8% | |
| Q3 2018 | -0.5% | -1.5% | -1.7% | |
| Q2 2018 | -11.6% | -11.4% | -6.3% | |
| Q1 2018 | -5.7% | -6.0% | -7.2% | |
| Q4 2017 | +5.8% | +4.9% | +8.4% | |
| Q3 2017 | +3.5% | +3.2% | -6.2% | |
| Q2 2017 | -6.8% | -7.7% | -13.0% | |
| Q1 2017 | +0.4% | -0.0% | +8.1% | |
| Q4 2016 | +1.3% | +2.3% | +14.7% | |
| Q3 2016 | -2.2% | -0.4% | +2.1% | |
| Q2 2016 | +7.6% | — | — | |
| Q1 2016 | +13.2% | — | — | |
| Q4 2015 | -12.4% | — | — | |
| Q3 2015 | -6.2% | — | — | |
| Q2 2015 | +0.8% | — | — | |
| Q1 2015 | -0.7% | — | — | |
| Q4 2014 | +5.2% | — | — | |
| Q3 2014 | -3.7% | — | — | |
| Q2 2014 | +9.2% | — | — | |
| Q1 2014 | -3.3% | — | — | |
| Q4 2013 | +3.1% | — | — | |
| Q3 2013 | -1.7% | — | — | |
| Q2 2013 | +0.0% | — | — | |
| Q1 2013 | +6.0% | — | — | |
| Q4 2012 | -0.3% | — | — | |
| Q3 2012 | +4.9% | — | — | |
| Q2 2012 | -2.2% | — | — | |
| Q1 2012 | +2.1% | — | — | |
| Q3 2009 | +0.3% | — | — | |
| Q4 2011 | +0.3% | — | — | |
| Q3 2011 | -13.6% | — | — | |
| Q2 2011 | +1.4% | — | — | |
| Q1 2010 | +1.3% | — | — | |
| Q1 2011 | +2.7% | — | — | |
| Q2 2010 | -1.6% | — | — | |
| Q4 2008 | -1.6% | — | — | |
| Q4 2010 | -1.6% | — | — | |
| Q4 2009 | +0.2% | — | — | |
| Q3 2010 | +0.2% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro